Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies: Comparative Effectiveness Review Number 61

Author:   Agency for Healthcare Resea And Quality ,  U S Department of Heal Human Services
Publisher:   Createspace Independent Publishing Platform
ISBN:  

9781483983776


Pages:   236
Publication Date:   28 March 2013
Format:   Paperback
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Our Price $63.33 Quantity:  
Add to Cart

Share |

Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies: Comparative Effectiveness Review Number 61


Add your own review!

Overview

Nephrolithiasis is a condition in which hard masses (kidney stones) form within the urinary tract. These stones form from crystals that separate out of the urine. The lifetime incidence of kidney stones is approximately 13 % for men and 7 % for women. Reports conflict regarding whether incidence is rising overall, but consistently report rising incidence in women and a falling male-to-female ratio. Direct medical expenditures associated with kidney stones may exceed $4.5 billion annually in the U.S. Approximately 80 % of adults with kidney stones have stones consisting predominately of calcium oxalate and/or calcium phosphate, with most remaining patients having either struvite or uric acid stones. Many patients with kidney stones have low urine volume and/or one or more biochemical abnormalities, including hypercalciuria, hyperuricosuria, hyperoxaluria, hypocitraturia, and either low or high urine pH. Risk of kidney stones also may be increased by medical conditions such as primary hyperparathyroidism, obesity, diabetes, gout, and intestinal malabsorption, and by anatomic abnormalities such as medullary sponge kidney and horseshoe kidney. Previous systematic reviews of randomized controlled trials (RCTs) of dietary and pharmacological therapies have reported that increased fluid intake, thiazide diuretics, and citrate pharmacotherapy reduce stone recurrence, but that evidence was insufficient regarding the efficacy of other pharmacological treatments. Clinical guidelines recommend that patients who experience kidney stones undergo a laboratory evaluation, including analysis of stone composition and possibly of urine and blood biochemistries. Unclear, however, is whether pretreatment laboratory test results predict effectiveness of treatment on stone recurrence and other clinical health outcomes, or whether treatment tailored to pretreatment laboratory results is associated with better clinical health outcomes than empiric therapy. Nor have followup biochemical test results been proven as valid surrogates for predicting the effectiveness of treatment in preventing stone recurrence. Clinical uncertainty exists regarding the effectiveness, comparative effectiveness, and adverse effects of dietary and pharmacological preventive treatments; the value of urine and blood biochemical measures for initiating and/or modifying treatment; and the potential impact of patient and stone characteristics on important treatment outcomes. This systematic review and meta-analysis attempts to comprehensively address these questions. We developed an analytic framework that incorporated six Key Questions and specified the patient populations, interventions, comparisons, outcomes, and harms of interest. The Key Questions were: 1. In adults with a history of nephrolithiasis, do results of baseline stone composition and blood and urine chemistries predict the effectiveness of diet and/or pharmacological treatment on final health outcomes and intermediate stone outcomes, and reduce treatment adverse effects? 2. In adults with a history of nephrolithiasis, what is the effectiveness and comparative effectiveness of different dietary therapies on final health outcomes and intermediate stone outcomes? 3. In adults with a history of nephrolithiasis, what is the evidence that dietary therapies to reduce risk of recurrent stone episodes are associated with adverse effects? 4. In adults with a history of nephrolithiasis, what is the effectiveness and comparative effectiveness of different pharmacological therapies on final health outcomes and intermediate stone outcomes? 5. In adults with a history of nephrolithiasis, what is the evidence that pharmacological therapies to reduce risk of recurrent stone episodes are associated with adverse effects? 6. In adults with a history of nephrolithiasis being treated to prevent stone recurrence, do results of followup blood and urine biochemistry measures predict final health outcomes and intermediate stone outcomes?

Full Product Details

Author:   Agency for Healthcare Resea And Quality ,  U S Department of Heal Human Services
Publisher:   Createspace Independent Publishing Platform
Imprint:   Createspace Independent Publishing Platform
Dimensions:   Width: 21.60cm , Height: 1.30cm , Length: 28.00cm
Weight:   0.558kg
ISBN:  

9781483983776


ISBN 10:   1483983773
Pages:   236
Publication Date:   28 March 2013
Audience:   General/trade ,  General
Format:   Paperback
Publisher's Status:   Active
Availability:   Available To Order   Availability explained
We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately.

Table of Contents

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List